Gwo-Tzer Ho talks with American Journal of Gastroenterology co-editor Brian Lacy about the developments in Precision Medicine, newly discovered IBD biomarkers that could be used to guide precision therapies, and the practical and ethical implications of these new developments in 2017.
Listen to Gwo-Tzer’s interview in American Journal of Gastroenterology